The upcoming Clinical Trials Supply and Outsourcing in Clinical Trials East Asia conferences will host discussions on supply ...

In this Science segment, we examine the European Medicines Agency's recent decision to recommend granting marketing ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended AstraZeneca's Tagrisso ...

The EMA recommended that NUZ-001, formerly monepantel, be granted orphan medicinal product designation to treat ALS in Europe ...

Samsung Biologics has secured two deals valued at 930.4 billion won ($668.4 million) with an unnamed European pharmaceutical ...

all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Clinuvel Pharmaceuticals is in advanced discussions with the ...

The global consumption of antibiotics in Portugal increased by 2% between 2019-2023, double the average increase of 1% in ...

As of late October, the company had obtained 339 regulatory approvals globally, including 38 from the US FDA and 33 from the ...

ImmunityBio (IBRX) announced new data from its ongoing QUILT 3.032 study. As of November, 100 patients with Bacillus Calmette-Guerin, or ...

UK MHRA grants marketing authorization to sparsentan to treat adult patients with primary immunoglobulin A nephropathy: United Kingdom Wednesday, November 20, 2024, 14:00 Hrs [IST ...

On Monday, BridgeBio Pharma, Inc. (NASDAQ:BBIO) presented initial outcomes from the ATTRibute-CM open-label extension (OLE) ...

Samsung Biologics said on Wednesday it surpassed the 5 trillion won ($3.59 billion) mark in its accumulated orders this year ...